ExodusPoint Capital Management »

Arrivent Biopharma shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $667k 36k 18.45
2025-06-30 $1.0M 48k 21.77
2025-03-31 $412k 22k 18.50

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ameren Corporation (AEE)
Merck & Co Call Option (MRK)
Nebius Group Shs Class A Put Option (NBIS)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Procter & Gamble Company (PG)
Evergy (EVRG)
Microsoft Corporation Put Option (MSFT)

View all positions for ExodusPoint Capital Management

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
Infinitum Asset Management
Suvretta Capital Management
FMR
OrbiMed Advisors
BlackRock
Vanguard Group
Octagon Capital Advisors
Novo A/S
Sofinnova Ventures
General Catalyst Group Management
State Street Corporation
Geode Capital Management
Siren
Sc China Holding

View all funds holding Arrivent Biopharma